Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-042623
Filing Date
2025-03-20
Accepted
2025-03-20 16:01:32
Documents
84
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vor-20241231.htm   iXBRL 10-K 3160018
2 EX-4.3 vor-ex4_3.htm EX-4.3 44235
3 EX-10.17 vor-ex10_17.htm EX-10.17 33583
4 EX-19.1 vor-ex19_1.htm EX-19.1 132390
5 EX-23.1 vor-ex23_1.htm EX-23.1 10729
6 EX-31.1 vor-ex31_1.htm EX-31.1 15019
7 EX-31.2 vor-ex31_2.htm EX-31.2 16664
8 EX-32.1 vor-ex32_1.htm EX-32.1 19556
9 EX-97.1 vor-ex97_1.htm EX-97.1 49170
  Complete submission text file 0000950170-25-042623.txt   11061460

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vor-20241231.xsd EX-101.SCH 1271391
86 EXTRACTED XBRL INSTANCE DOCUMENT vor-20241231_htm.xml XML 1837054
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39979 | Film No.: 25756365
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)